Medicamentele pentru slăbit ar putea avea un beneficiu neașteptat. Ce arată un nou studiu

A recent study indicates that GLP-1 medications may reduce fracture risk in type 2 diabetes patients, suggesting potential direct benefits for bone health. The research analyzed medical records of over 133,000 adults, revealing a 21% lower risk of fractures for those on GLP-1 drugs compared to DPP-4 medications. Notably, vertebral and hip fractures showed significant risk reductions. However, the study does not establish causation and highlights the need for further controlled clinical trials to confirm these findings.